Stanzani M - Search Results

1

Management of drug-drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs.

Brüggemann RJ, Verheggen R, Boerrigter E, Stanzani M, Verweij PE, Blijlevens NMA, Lewis RE. Brüggemann RJ, et al. Among authors: stanzani m. Lancet Haematol. 2022 Jan;9(1):e58-e72. doi: 10.1016/S2352-3026(21)00232-5. Epub 2021 Dec 8. Lancet Haematol. 2022. PMID: 34890539 Review.

2

Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature.

Stanzani M, Cricca M, Sassi C, Sutto E, De Cicco G, Bonifazi F, Bertuzzi C, Bacci F, Paolini S, Cavo M, Lewis RE. Stanzani M, et al. Mycoses. 2019 Dec;62(12):1100-1107. doi: 10.1111/myc.12978. Epub 2019 Oct 21. Mycoses. 2019. PMID: 31365161 Review.

3

The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies.

Sassi C, Stanzani M, Lewis RE, Facchini G, Bazzocchi A, Cavo M, Battista G. Sassi C, et al. Among authors: stanzani m. Br J Radiol. 2018 Feb;91(1083):20170220. doi: 10.1259/bjr.20170220. Epub 2018 Jan 10. Br J Radiol. 2018. PMID: 29212355 Free PMC article.

4

Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease.

Stanzani M, Lewis RE. Stanzani M, et al. J Fungi (Basel). 2018 Dec 19;4(4):141. doi: 10.3390/jof4040141. J Fungi (Basel). 2018. PMID: 30572637 Free PMC article. Review.

5

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies.

Stanzani M, Vianelli N, Cavo M, Kontoyiannis DP, Lewis RE. Stanzani M, et al. J Infect. 2019 Jun;78(6):484-490. doi: 10.1016/j.jinf.2019.04.002. Epub 2019 Apr 8. J Infect. 2019. PMID: 30974130

6

Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease.

Stanzani M, Sassi C, Battista G, Lewis RE. Stanzani M, et al. Med Mycol. 2019 Jun 1;57(Supplement_3):S274-S286. doi: 10.1093/mmy/myy125. Med Mycol. 2019. PMID: 31292659

7

A risk prediction score for invasive mold disease in patients with hematological malignancies.

Stanzani M, Lewis RE, Fiacchini M, Ricci P, Tumietto F, Viale P, Ambretti S, Baccarani M, Cavo M, Vianelli N. Stanzani M, et al. PLoS One. 2013 Sep 26;8(9):e75531. doi: 10.1371/journal.pone.0075531. eCollection 2013. PLoS One. 2013. PMID: 24086555 Free PMC article.

8

Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma.

Sassi C, Stanzani M, Lewis RE. Sassi C, et al. Among authors: stanzani m. Br J Haematol. 2015 May;169(4):462. doi: 10.1111/bjh.13356. Epub 2015 Mar 29. Br J Haematol. 2015. PMID: 25818621 Free article. No abstract available.

9

Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies.

Stanzani M, Vianelli N, Cavo M, Maritati A, Morotti M, Lewis RE. Stanzani M, et al. Antimicrob Agents Chemother. 2017 Aug 24;61(9):e02651-16. doi: 10.1128/AAC.02651-16. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28607011 Free PMC article.

10

Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study.

Stanzani M, Sassi C, Lewis R, Sartor C, Rasetto G, Cavo M, Battista G. Stanzani M, et al. J Infect. 2021 Sep;83(3):371-380. doi: 10.1016/j.jinf.2021.06.019. Epub 2021 Jun 24. J Infect. 2021. PMID: 34171366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters